Venus Remedies Ltd.
NSE: VENUSREM | BSE: 526953
₹1,030.55
₹-11.95
(-1.15%)
As on 21-May-2026IST
Market cap
₹1,379 Cr
Revenue (TTM)
₹700 Cr
P/E Ratio
18.1
P/B Ratio
2.2
Div. Yield
0 %
Quality Score
7/10
Growth Score
8/10
Valuation Score
4/10
Momentum Score
10/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹76 Cr
-
ROE
8.6 %
-
ROCE
13.2 %
-
Industry P/E
31.68
-
EV/EBITDA
10.5
-
Debt to Equity
0
-
Book Value
₹463.7
-
EPS
₹57.1
-
Face value
10
-
Shares outstanding
13,366,988
10 Years Aggregate
CFO
₹593.22 Cr
EBITDA
₹543.74 Cr
Net Profit
₹118.21 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Venus Remedies
| 34.5 | 0.8 | 35.7 | 208.8 | 72.6 | 27.5 | 29.6 |
|
BSE Healthcare
| 10.2 | 10.3 | 11.1 | 13.4 | 28.1 | 14.5 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Venus Remedies
| 140.6 | -21.4 | 124.3 | -55.7 | 147.5 | 587.2 | -49.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Venus Remedies
|
1,030.6 | 1,378.7 | 699.9 | 76.3 | 12.0 | 13.2 | 18.1 | 2.2 |
| 3,149.2 | 39,331.0 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 37.2 | 8.7 | |
| 8,589.5 | 21,445.4 | 2,177.5 | 200.9 | 11.3 | 26.5 | 106.8 | 25.8 | |
| 2,025.9 | 15,373.0 | 2,187.2 | 649.7 | 31.5 | 19 | 24 | 4.3 | |
| 1,385.9 | 19,193.0 | 3,129.4 | 647.4 | 26.9 | 18.1 | 31 | 4.9 | |
| 2,178.9 | 34,956.8 | 4,147.8 | 709.5 | 22.3 | 18.3 | 49.3 | 8.4 | |
| 4,651.3 | 21,312.5 | 2,519.7 | 722.4 | 33.6 | 18.8 | 29.5 | 5.1 | |
| 5,455.0 | 9,032.1 | 1,348.5 | 293.5 | 28.1 | 50.7 | 30.8 | 13.0 | |
| 474.7 | 9,293.1 | 1,432.0 | 149.0 | 19.1 | 7.9 | 61.9 | 3.7 | |
| 1,159.1 | 10,681.9 | 4,858.7 | 574.1 | 14.9 | 19.7 | 19.2 | 3.4 |
Shareholding Pattern
View DetailsNews & Analysis
All News
2 min read•By Research Desk
2 min read•By Research Desk
About Venus Remedies
Venus Remedies Limited engages in the pharmaceutical business in India and internationally. It is involved in the research and development of solutions focusing on antimicrobial resistance and oncology. The company also offers analgesic, analgesic... and antipyretic, antibiotic, anticoagulant, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormones (steroid), immunostimulating agent, iron supplements, muscle relaxant, neurology, oncology, and solvent products, as well as herbal medicine. The company was incorporated in 1989 and is headquartered in Panchkula, India. Read more
-
Incorporated
1989
-
Chairman
Pawan Chaudhary
-
Managing Director
Pawan Chaudhary
-
Headquarters
Chandigarh, Union Territory
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsSocial Media Post On KYC Updation
21-May-2026Corporate Action-Board to consider Dividend
15-May-2026No News & Announcements are available.
FAQs for Venus Remedies
What is the current share price of Venus Remedies Ltd Today?
The share price of Venus Remedies Ltd is ₹1,030.55 (NSE) and ₹1,031.40 (BSE) as of 21-May-2026 IST. Venus Remedies Ltd has given a return of 72.64% in the last 3 years.
What is the current PB & PE ratio of Venus Remedies Ltd?
The P/E ratio of Venus Remedies Ltd is 18.07 times as on 21-May-2026, a 43 discount to its peers’ median range of 31.68 times.
The P/B ratio of Venus Remedies Ltd is 2.22 times as on 21-May-2026, a 52 discount to its peers’ median range of 4.65 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
8.84
|
0.71
|
|
2024
|
15.31
|
0.89
|
|
2023
|
8.15
|
0.47
|
|
2022
|
8.82
|
0.82
|
|
2021
|
5.49
|
0.88
|
What is the 52 Week High and Low of Venus Remedies Ltd?
The 52-week high and low of Venus Remedies Ltd are Rs 1,088.80 and Rs 332.60 as of 21-May-2026.
What is the market cap of Venus Remedies Ltd?
Venus Remedies Ltd has a market capitalisation of ₹ 1,379 Cr as on 21-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Venus Remedies Ltd?
Before investing in Venus Remedies Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.